How Exonate Plans to Revolutionize Diabetic Eye Disease Treatment: A Convo with Dr. Catherine Beech

In this episode of “In Focus,” Julie Schlosser sits down with Dr. Catherine Beech, CEO of biotech company Exonate, to discuss their cutting-edge work in ophthalmology. Exonate is focused on developing a groundbreaking eye drop treatment for diabetic eye disease, aiming to replace the need for invasive injections into the eye. Dr. Beech shares the science behind their compound and the promising results from their recent clinical trials. She also discusses Exonate’s potential impact of their affordable and accessible treatment on a global scale. Don’t miss this insightful conversation about the future of eye care.

Our In Focus newsletter is published once a month and has thousands of subscribers. To help you keep in touch, you can subscribe here.